期刊
REGENERATIVE THERAPY
卷 2, 期 -, 页码 2-5出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.reth.2015.07.002
关键词
iPS cells; Regenerative therapy; Act on the Safety of Regenerative Medicine; Pharmaceuticals; Medical Devices and Other Therapeutic; Products Act; Cell sheet techniques; Macular degeneration; Retinal pigmented epithelium (RPE)
资金
- Astellas Pharma Inc.
- CSL Behring K.K.
- Edwards Lifesciences Co.
- Konishi Medical Instruments Co. Ltd.
- Miyano Medical Instruments Co. Ltd.
- MSD K.K.
- Ono Pharmaceutical Co. Ltd.
- Terumo Co.
- 2nd Regenerative Medicine Expo & Conference Japan
- Acute Support Co. Ltd.
- Asahi Kasei Co.
- Biotherapy Institute of Japan
- CellSeed Inc.
- Cyfuse Biomedical K.K.
- Cytori Therapeutics Inc.
- DValue Service GK.
- Dai Nippon Printing Co. Ltd.
- Dai-Dan Co. Ltd.
- Forum for Innovative Regenerative Medicine
- Fujifilm Co.
- Fujimori Kogyo Co. Ltd.
- Hamaguchi Lab.
- Healios K.K.
- Hitachi, Ltd.
- Horiba, Ltd.
- iHeart Japan Co.
- Ikeda Scientific Co. Ltd.
- iPS Academia Japan, Inc.
- IS Technology Japan, Inc.
- Japan Tissue Engineering Co. Ltd.
- JCR Pharmaceuticals Co. Ltd.
- Kaneka Co.
- Kiwa Laboratory Animals Co. Ltd.
- MC Co. Ltd. Medinet Co. Ltd.
- Menicon Co. Ltd.
- Mitsui Sumitomo Insurance Co. Ltd.
- Nihon Kohden Co.
- Oriental Motor Co. Ltd.
- Panasonic Healthcare Co. Ltd.
- PMT Co.
- Regience K.K.
- Rohto Pharmaceutical Co. Ltd.
- Sekisui Seikei Co. Ltd.
- Shibuya Kogyo Co. Ltd.
- Shimadzu Co.
- Shin Nippon Biomedical Laboratories, Ltd.
- Sompo Japan Nipponkoa Insurance Inc.
- Sony Co.
- Sumitomo Dainippon Pharma Co. Ltd.
- Taisho Toyama Pharmaceutical Co. Ltd.
- Technos Yashima Co. Ltd.
- Tella, Inc.
- Toyo Seikan Group Holdings, Ltd.
- Veritas Co.
- Yashima Pure Chemicals Co. Ltd.
The Symposium of Regenerative Medicine for Patients, organized by the Japanese Society for Regenerative Medicine, was held on 28 September 2014 in Tokyo, Japan. The event provided an overview of the important areas of cell-based medicine, and highlighted the first-in-human clinical trial of induced pluripotent stem cell (iPSC)-derived products. Recent advances in regenerative medicine were also discussed, especially regarding the use of somatic cells such as chondrocytes, skeletal myocytes and cardiomyocytes under both the Act on the Safety of Regenerative Medicine, and the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act. (C) 2015, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
